New Key Statistics Module, Z-Score and F-Score
NAS:RPRX Key Ratios
| Market Cap $ M | 12,489.50 |
| Enterprise Value $ M | 17,364.23 |
| P/E(ttm) | 11.10 |
| PE Ratio without NRI | 14.02 |
| Forward PE Ratio | 8.24 |
| Price/Book | 1.91 |
| Price/Sales | 7.16 |
| Price/Free Cash Flow | 5.64 |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.40 |
| Revenue (TTM) $ M | 2,354.00 |
| EPS (TTM) $ | 2.52 |
| Beneish M-Score | -3.03 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -23.00 |
| y-y EBITDA Growth Rate % | 223.70 |
| EV-to-EBIT | 9.20 |
| EV-to-EBITDA | 9.20 |
| PEG | -- |
| Shares Outstanding M | 446.69 |
| Net Margin (%) | 48.20 |
| Operating Margin % | 63.37 |
| Pre-tax Margin (%) | 72.20 |
| Quick Ratio | 7.90 |
| Current Ratio | 7.90 |
| ROA % (ttm) | 6.82 |
| ROE % (ttm) | 18.59 |
| ROIC % (ttm) | 9.93 |
| Dividend Yield % | 2.91 |
| Altman Z-Score | 2.01 |
| Piotroski F-Score | 6.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | N |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | Y |
RPRX Number of Guru Trades
RPRX Volume of Guru Trades
Gurus Latest Trades with NAS:RPRX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RPRX is held by these investors
Total 1
Royalty Pharma PLC Insider Transactions
No Available Data
News about NAS:RPRX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers